Study: Targeted Approach for Harm Reduction Using E-Cigarettes

Sep.19.2022
Study: Targeted Approach for Harm Reduction Using E-Cigarettes
A study emphasizes the need for e-cigarettes as a harm reduction tool and explores its potential to aid in smoking cessation.

A study published in the Journal of American Drug and Alcohol Abuse reaffirmed the necessity of using electronic cigarettes (EC) as a tool to reduce harm.


The title of this paper is "A Targeted Approach Using E-cigarettes to Reduce Adult Harm", which emphasizes the negative perception of e-cigarettes and the inaccurate belief that they are as harmful as or more harmful than combustible cigarettes, representing a missed opportunity in public health.


This paper outlines the necessity of this view and openly explores the potential use of electronic cigarettes (EC) as a way of reducing harm for smokers who find it difficult to quit. Recent reviews of randomized controlled trials and network meta-analyses on using electronic cigarettes to quit smoking have found that smokers who were given nicotine electronic cigarettes were more likely to stay smoke-free compared to those given permission to use nicotine replacement therapy (NRT).


EC and NRT. (Note: This is already in English and does not require translation.)


The study titled "Systematic Review of Randomized Controlled Trials and Network Meta-analysis Comparing E-Cigarettes to Approved Nicotine Replacement Therapy (NRT) and Non-Nicotine Based Smoking Cessation" examines the effectiveness of nicotine-based e-cigarettes compared to NRT and non-nicotine based methods for quitting smoking. The research analyzes controlled conditions to determine which method is most effective.


Researchers conducted a search in PubMed, Web of Science, and PsycINFO for randomized controlled trials (RCTs) that allocated individuals to use nicotine electronic cigarettes compared to those using licensed nicotine replacement therapy (NRT) such as nicotine patches or gum, or placebo. The study only included research involving healthy smoking participants.


A research team has sifted through thousands of studies and found that smokers who switch to nicotine electronic cigarettes are more likely to quit smoking than those who remain on standard smoking cessation methods. "Smokers allocated to e-cigarettes were more likely to have quit smoking than those allocated to nicotine-replacement therapy, and both were more effective than standard care or placebo conditions. Due to the risk of bias in the studies included, more high-quality research is needed to determine the impact of e-cigarettes on smoking cessation," the study concluded.


Statement:


This article draws from third-party sources and is intended solely for professional industry exchange and learning purposes.


This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot verify the authenticity and accuracy of its content. The translation of this article is only meant for industry exchange and research purposes.


Due to limitations in our ability to accurately translate, the translated article may not faithfully convey the meaning of the original text. We advise readers to refer to the original text for accuracy.


2FIRSTS maintains full alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or international issues and positions.


The copyright of compiled information belongs to the original media and author, and if there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
A court declaration signed by FDA official Melanie M. Keller on March 24, 2026 detailed the status of previously issued reduction-in-force notices affecting employees at the Center for Tobacco Products (CTP).
Apr.01 by 2FIRSTS.ai
Scandinavian Tobacco Group releases 2025 results: tariffs and weaker demand weigh on performance, revenue about $1.4 billion
Scandinavian Tobacco Group releases 2025 results: tariffs and weaker demand weigh on performance, revenue about $1.4 billion
Scandinavian Tobacco Group (STG) reported its 2025 results: revenue was 9.036 billion Danish kroner (about $1.407 billion); EBITDA before special items was 1.791 billion Danish kroner (about $278 million); and free cash flow before acquisitions was 595 million Danish kroner (about $92.7 million). Multiple metrics declined year over year, and the company did not meet its Q3-updated guidance for revenue and free cash flow.
Mar.05 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Breaking: Smoore Shares Fall More Than 16% Intraday in Morning Trade After Results Release, Investor Presentation
Breaking: Smoore Shares Fall More Than 16% Intraday in Morning Trade After Results Release, Investor Presentation
Smoore International (6969.HK) released its 2025 results on March 17 and held an investor presentation on the morning of March 18. In morning trade on March 18, the company’s shares fell more than 16% intraday, hitting a low of HK$9.94.
Mar.18 by 2FIRSTS.ai
Philip Morris Korea Launches New IQOS ILUMA i “Electric Purple” Color Edition
Philip Morris Korea Launches New IQOS ILUMA i “Electric Purple” Color Edition
Philip Morris Korea said it has launched a new color edition of its heated tobacco device brand IQOS, called “IQOS ILUMA i Electric Purple.” The new color has been added to the IQOS ILUMA i series and applies to the Prime, standard, and One variants. The product is being sold through the IQOS website and nine IQOS directly operated stores across South Korea.
Mar.12 by 2FIRSTS.ai